Related Articles
Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene.
Cx32 mediates cisplatin resistance in human ovarian cancer cells by affecting drug efflux transporter expression and activating the EGFR‑Akt pathway
Cisplatin and phorbol ester independently induce ERCC-1 protein in human ovarian carcinoma cells.
Effect of the proteasome inhibitor ALLnL on cisplatin sensitivity in human ovarian tumor cells
Phosphorylation of glycogen synthase kinase-3 β at serine 9 confers cisplatin resistance in ovarian cancer cells